On Aug. 1, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On July 28, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On July 27, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

FDA will set the fiscal year 2023 fee for its Voluntary Qualified Import Program at $12,962, it said in a notice. The fee, down from $15,938 last year (see 2107270015), is required from food importers to begin participation in the VQIP trusted trader program for the period beginning Oct. 1, FDA said. The fee will remain in effect through Sept. 30, 2023, it said.

FDA set potential fiscal year 2023 fees for import reinspections, domestic and foreign facility reinspections, and recall activities the agency performs if a firm fails to comply with a mandatory recall order, though it still isn't invoicing for services associated with the fees, it said in a notice. The agency set FY23 fees of $281 per hour for domestic services involving travel and $334 hourly if foreign travel is required.

On July 25, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On July 22, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On July 21, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On July 20, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

FDA has issued its Enforcement Report for July 20, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.